Literature DB >> 1723721

Simultaneous immunohistochemical demonstration of vasoactive intestinal polypeptide and its receptor in human colon.

W Kummer1.   

Abstract

The present study reports an immunohistochemical approach for localizing the immunoreactivity of vasoactive intestinal polypeptide (VIP) receptor in the human colon, by using a monoclonal antibody which recognizes the VIP-receptor of a human colonic adenocarcinoma cell line. Simultaneous demonstration of immunoreactive VIP-receptor of a human colonic adenocarcinoma cell line. Simultaneous demonstration of immunoreactive VIP-receptor and VIP was achieved by a double-labelling procedure employing immunogold silver staining for VIP-receptor, and a biotinylated secondary antibody followed by streptavidin-Texas Red, to visualize VIP. The immunoreactive VIP receptor was found at two locations receiving dense VIP innervation: myenteric ganglia and mucosal epithelium. Epithelial cells displayed intense labelling at the basolateral membrane, which confirmed earlier binding studies on fractionated membranes. A small number of enteroendocrine cells was also recognized by the VIP-receptor antibody. Smooth muscle and cells of the immune system were not stained by the monoclonal antibody, indicating that it recognized an epitope not common to VIP-receptors of all locations. Thus, the immunohistochemical approach of VIP-receptor localization differs from autoradiography in (a) precise cellular localization, (b) possibility of simultaneous demonstration of receptor and ligand immunoreactivity, and (c) selectivity to a certain receptor population which, however, is presently not fully characterized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1723721     DOI: 10.1007/bf01387180

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  34 in total

1.  Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat.

Authors:  L C Racusen; H J Binder
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

3.  cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea.

Authors:  S C Lazarus; C B Basbaum; P J Barnes; W M Gold
Journal:  Am J Physiol       Date:  1986-07

4.  Autoradiographic distribution of vasoactive intestinal polypeptide receptors in rabbit and rat small intestine.

Authors:  H Sayadi; J W Harmon; T W Moody; L Y Korman
Journal:  Peptides       Date:  1988 Jan-Feb       Impact factor: 3.750

5.  Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.

Authors:  C L Wood; M S O'Dorisio; L M Vassalo; W B Malarkey; T M O'Dorisio
Journal:  Regul Pept       Date:  1985-11-07

6.  Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells.

Authors:  Y Yajima; Y Akita; T Saito
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

7.  Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.

Authors:  K Dharmsathaphorn; V Harms; D J Yamashiro; R J Hughes; H J Binder; E M Wright
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

8.  Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome.

Authors:  I M Modlin; S R Bloom; S J Mitchell
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

9.  Anti-cell surface monoclonal antibodies which antagonize the action of VIP in a human adenocarcinoma cell line (HT 29 cells).

Authors:  J Pichon; M Hirn; J M Muller; P Mangeat; J Marvaldi
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  A simple method for removing the resin from epoxy-embedded tissue.

Authors:  H D MAYOR; J C HAMPTON; B ROSARIO
Journal:  J Biophys Biochem Cytol       Date:  1961-04
View more
  1 in total

1.  Vasoactive intestinal polypeptide immunoreactivity in the human cerebellum: qualitative and quantitative analyses.

Authors:  Vincenzo Benagiano; Paolo Flace; Loredana Lorusso; Anna Rizzi; Lorenzo Bosco; Raffaele Cagiano; Glauco Ambrosi
Journal:  J Anat       Date:  2009-06-22       Impact factor: 2.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.